Oncology

Overview

The increasing number of drug candidates that target specific gene expressions and small molecular receptors have created a great challenge to pharmaceutical and biotech companies to carefully select agents demonstrating safety and clinical benefits.

At PharmaLegacy we provide various animal models to assist cancer researchers in biological and mechanistic studies. In particular we have comprehensive models in immunodeficient rodents as screening tools to support drug efficacy assessment.